The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia

ConclusionUsing both the anchor‐based and distribution‐based approaches, the estimated MID for the ESS in HHT is 0.71. Further implications include key metrics to help guide treatment responses in clinical care and essential information to calculate power and sample size for future clinical trials.
Level of Evidence4. Laryngoscope, 2015

Source: The Laryngoscope - September 22, 2015 Category: ENT & OMF Authors: Linda X. Yin, Douglas D. Reh, Jeffrey B. Hoag, Sally E. Mitchell, Stephen C. Mathai, Gina M. Robinson, Christian A. Merlo Tags: Allergy/Rhinology Source Type: research